Gaelic Laboratories gains Kitemark certification for minimized risk of AMR
Certification recognizes responsible antibiotic manufacturing practices and environmental risk management
11 Jun 2026Industry news
Gaelic Laboratories has achieved BSI Kitemark™ Certification for Minimized Risk of AMR, recognizing the company’s responsible antibiotic manufacturing practices and environmental risk management.
The certification follows many months of work to ensure that Gaelic Laboratories’ facilities meet stringent requirements for minimizing the risk of antimicrobial resistance (AMR) and aquatic ecotoxicity in the environment, providing assurance to partners and customers across Ireland, Europe and other regions.
Commitment to responsible antibiotic manufacturing
The attainment of BSI Kitemark Certification for Minimized Risk of AMR represents a gold-standard accreditation for responsible manufacturing in the global antibiotic supply chain.
The certification confirms that Gaelic Laboratories practices the responsible manufacturing of antibiotics and addresses environmental waste concerns. The company commits to an approved framework for managing antibiotic discharge and to good practice methods designed to avoid the environmental impact of manufacturing discharges.
Gaelic Laboratories also continually reviews its manufacturing and supply chains to ensure good practice in controlling releases of antibiotics into the environment.
Alignment with the AMR Industry Association’s Antibiotic Manufacturing Standard
The BSI Kitemark has transitioned recently to align with the May 2025 release of the AMR Industry Association’s Antibiotic Manufacturing Standard, which has been effective from January 1, 2026. This Standard provides clear guidance to manufacturers in the global antibiotic supply chain to ensure that antibiotics are made responsibly, helping to minimize the risk of AMR in the environment.
By achieving this certification, Gaelic Laboratories demonstrates that its manufacturing operations are aligned with these evolving international expectations for sustainable pharmaceutical manufacturing and environmental risk management.
Pathway to AMR Industry Alliance membership
Having obtained the certification, Gaelic Laboratories is now eligible to apply for AMR Industry Alliance membership. The AMR Industry Alliance is one of the largest private sector coalitions established to provide sustainable solutions to curb AMR globally, with over 90 biotech, diagnostics, generics and research-based pharmaceutical companies and associations joining forces.
Brian Morrissey, General Manager of Gaelic Laboratories, said, “We are very much looking forward to Gaelic and Athlone Laboratories (our sister company) joining this industry group. We share the goals in terms of providing critical medicines for patients in Ireland, Europe and other parts of the world, while leveraging best-practices to support a broad industry momentum to fight AMR. Membership of this Alliance will better enable us to support those objectives, along with other leading pharmaceutical manufacturers across the world.”
Want the latest science news straight to your inbox? Become a SelectScience member for free today>>
Frequently asked questions
What is the BSI Kitemark Certification for Minimized Risk of AMR achieved by Gaelic Laboratories, and why is it important for antibiotic manufacturing?
Gaelic Laboratories, based in Ireland, has achieved BSI Kitemark Certification for Minimized Risk of AMR, a gold-standard accreditation that recognizes responsible antibiotic manufacturing practices and environmental risk management. This certification confirms that the company minimizes the risk of antimicrobial resistance (AMR) and aquatic ecotoxicity by managing antibiotic discharge and controlling releases of antibiotics into the environment. It provides assurance to partners and customers in Ireland, Europe and other regions that Gaelic Laboratories operates to stringent standards in the global antibiotic supply chain.
How does Gaelic Laboratories align its antibiotic manufacturing operations with the AMR Industry Association’s Antibiotic Manufacturing Standard?
Gaelic Laboratories’ BSI Kitemark Certification has transitioned to align with the May 2025 release of the AMR Industry Association’s Antibiotic Manufacturing Standard, which has been effective since January 1, 2026. By achieving this certification, Gaelic Laboratories demonstrates that its antibiotic manufacturing and environmental risk management practices follow the clear guidance set out for the global antibiotic supply chain. This alignment shows that the company supports evolving international expectations for sustainable pharmaceutical manufacturing and minimizing the risk of AMR in the environment.
What role does Gaelic Laboratories’ BSI Kitemark Certification play in its pathway to AMR Industry Alliance membership and global AMR risk reduction?
Having obtained the BSI Kitemark Certification for Minimized Risk of AMR, Gaelic Laboratories is now eligible to apply for membership of the AMR Industry Alliance, a large private sector coalition with over 90 biotech, diagnostics, generics and research-based pharmaceutical companies and associations. This certification underpins Gaelic Laboratories’ commitment to providing critical medicines for patients in Ireland, Europe and other parts of the world while leveraging best practices to reduce AMR risk.
Joining the AMR Industry Alliance will enable Gaelic Laboratories and its sister company, Athlone Laboratories, to contribute more effectively to global initiatives aimed at curbing antimicrobial resistance and promoting sustainable pharmaceutical manufacturing.